CTOs on the Move

ZoomMed

www.zoommed.com

 
ZoomMed inc. is a Brossard, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.zoommed.com
  • 6300 av Auteuil Ste 121
    Brossard, QC CAN J4Z 3P2
  • Phone: 450.678.5457

Executives

Name Title Contact Details

Similar Companies

BSD Medical Corporation

BSD Medical Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Salt Lake City, UT. To find more information about BSD Medical Corporation, please visit www.bsdmc.com

EDIX12

EDIX12 is a Hicksville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Virginia Premier Health Plan Inc

Virginia Premier Health Plan, Inc. is a Health Maintenance Organization (HMO, IPA model), which began operations as a full service Medicaid HMO in August 1995. VPHP is contracted with the Virginia Department of Medical Assistance Services to provide

Community Health Centers Alliance

Community Health Centers Alliance is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.